Randomized Phase III Trial of Piroxicam in Combination with Mitoxantrone or Carboplatin for First‐Line Treatment of Urogenital Tract Transitional Cell Carcinoma in Dogs

BACKGROUND: Reported response rates of transitional cell carcinoma (TCC) in dogs to piroxicam in combination with either mitoxantrone or carboplatin are similar; however, it is unknown whether either drug might provide superior duration of response. HYPOTHESIS/OBJECTIVES: To determine if the progres...

Descripción completa

Detalles Bibliográficos
Autores principales: Allstadt, S.D., Rodriguez, C.O., Boostrom, B., Rebhun, R.B., Skorupski, K.A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2015
Materias:
Standard Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4858101/
https://www.ncbi.nlm.nih.gov/pubmed/25619518
http://dx.doi.org/10.1111/jvim.12533

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4858101/
https://www.ncbi.nlm.nih.gov/pubmed/25619518
http://dx.doi.org/10.1111/jvim.12533

Ejemplares similares